There is no single “best” inhaler for everyone with asthma, but current guidelines are clear on one point: every person with asthma should be using an inhaler that contains a corticosteroid, not a quick-relief bronchodilator alone. The preferred approach for most adults and adolescents is a combination inhaler that pairs a low-dose corticosteroid with formoterol, used as needed for symptoms and, at higher steps, as a daily controller. This strategy cuts the risk of severe flare-ups by 60% to 64% compared to using a quick-relief inhaler on its own.
Why a Steroid-Containing Inhaler Comes First
Asthma is fundamentally an inflammatory disease. A quick-relief bronchodilator (often called a “rescue” inhaler) opens your airways fast, but it does nothing about the underlying inflammation driving your symptoms. Using one without any corticosteroid coverage leaves that inflammation unchecked, which raises your odds of a serious attack, a hospital visit, or worse.
International treatment guidelines updated in 2024 now recommend that no adult or adolescent with asthma rely on a short-acting bronchodilator alone. Instead, every puff of quick relief should come alongside an inhaled corticosteroid, either in the same device or taken separately.
The Two Recommended Treatment Approaches
Current guidelines lay out two main paths, depending on what your doctor prescribes and what’s available to you.
Track 1: Combination Corticosteroid-Formoterol (Preferred)
In this approach, you carry a single combination inhaler containing a low-dose corticosteroid plus formoterol, a fast-acting bronchodilator that also works over the long term. For mild asthma, you use it only when symptoms appear. As asthma severity increases, you add daily maintenance puffs of the same inhaler while still using extra puffs for rescue. The advantage is simplicity: one device handles both prevention and relief. Clinical trials show this reduces severe flare-ups by more than 50% compared to using a traditional rescue inhaler, with lower rates of hospitalization and less need for oral steroids. Budesonide-formoterol is the most widely studied combination for this purpose, available generically as well as under brand names like Symbicort.
Track 2: Separate Rescue Inhaler Plus a Controller
If a combination device isn’t available or isn’t right for you, the alternative is to take a puff of your corticosteroid inhaler every time you use your short-acting rescue inhaler. As severity increases, you move to taking the corticosteroid daily as a scheduled maintenance treatment. This path works, but it requires you to manage two devices and remember to pair them. For many people, that extra step gets skipped, which is one reason the single-combination approach is preferred when possible.
Stepping Up Treatment for Moderate to Severe Asthma
Asthma treatment works like a staircase. If low-dose combination therapy doesn’t keep your symptoms controlled, the next steps involve increasing the corticosteroid dose or adding a second long-acting bronchodilator that works through a different mechanism. At the highest conventional step, some people use triple therapy: a corticosteroid, a long-acting bronchodilator, and a second type of long-acting airway opener all in one inhaler. Trelegy Ellipta is one example of a triple-therapy device, though it was originally developed for COPD and its role in asthma is more limited.
For the roughly 5% to 10% of people whose asthma remains uncontrolled despite maximum inhaler therapy, injectable biologic medications become an option. These target specific immune pathways. Eligibility typically depends on blood test results showing high levels of certain immune cells or antibodies, along with a documented history of frequent flare-ups requiring oral steroids. Biologics are not inhalers, but they can reduce dependence on high-dose inhaled and oral steroids.
Choosing the Right Delivery Device
The medication inside the inhaler matters most, but the device you use to deliver it makes a real difference too. The two main types are pressurized metered-dose inhalers (the classic “puff” canister) and dry powder inhalers (which release medication when you breathe in forcefully). Both work, but technique errors are extremely common: studies show that about 87% of people using a metered-dose inhaler and 61% using a dry powder inhaler make at least one mistake that can reduce how much medication reaches their lungs.
With a metered-dose inhaler, the most common problem is poor coordination between pressing the canister and breathing in. Adding a spacer, a tube that attaches to the inhaler, largely solves this. Spacers boost lung delivery from a range of 8% to 53% without one, up to 11% to 68% with one. They also reduce the amount of medication deposited in your mouth and throat, which lowers the chance of local side effects. A dry powder inhaler doesn’t need a spacer, but it does require a strong, fast inhalation to pull the powder into your lungs. People with very limited lung function or young children may not generate enough airflow to use one effectively.
Inhalers for Children Under 6
Young children should use a metered-dose inhaler paired with a valved spacer. Children under about 4 also need a face mask attached to the spacer because they can’t reliably seal their lips around a mouthpiece. A typical child takes 5 to 10 breaths to empty the spacer chamber. Nebulizers, which convert liquid medication into a mist, are the only alternative for very young children who can’t use a spacer effectively. The medications are the same; only the delivery method differs.
Common Side Effects of Inhaled Corticosteroids
The most frequent side effect is hoarseness or voice changes, reported in 5% to 50% of users depending on the study and the dose. Oral thrush, a yeast infection in the mouth, is another possibility, particularly in older adults. Both are largely preventable by rinsing your mouth with water after each use and by using a spacer, which keeps more of the drug out of your throat.
Systemic side effects, the kind that affect your whole body, are rare at low and medium doses. Children on medium to high doses may experience a small growth delay averaging about 1 centimeter, though this tends to be temporary and does not affect final adult height in most studies. Serious complications like bone thinning or hormonal disruption are essentially limited to prolonged use of high doses. For the vast majority of people with asthma, the risk of an uncontrolled flare-up far outweighs the risk of side effects from their corticosteroid inhaler.
Generic Options and Cost
Cost is a real barrier, and it’s worth knowing that several major combination inhalers are now available in generic form in the United States. Generic versions of fluticasone-salmeterol (the medication in Advair) and budesonide-formoterol (the medication in Symbicort) are both on the market. Generics contain the same active ingredients at the same doses and must meet the same regulatory standards. If you’re paying out of pocket or facing high copays, asking your pharmacist or doctor about a generic equivalent is one of the most straightforward ways to lower cost without changing your treatment.